Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001492422-17-000001
Filing Date
2017-08-17
Accepted
2017-08-17 13:39:18
Documents
1
Effectiveness Date
2017-08-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15230
  Complete submission text file 0001492422-17-000001.txt   16364
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

EIN.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-293019 | Film No.: 171038264
SIC: 2834 Pharmaceutical Preparations